![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
Direxion Daily Energy Bear 2X Shares
ERY
Direxion Daily Financial Bull 3X Shares ETF
FAS
4
SPDR S&P Homebuilders ETF
XHB
5
VanEck Semiconductor ETF
SMH
US Stock MarketDetailed Quotes
NewcelX (NCEL)
- 3.540
- +0.050+1.43%
Close Jun 23 15:58 ET
- 3.450
- -0.090-2.54%
Post 20:01 ET
19.06MMarket Cap-2.05P/E (TTM)
3.590High3.332Low6.15KVolume3.580Open3.490Prev Close21.58KTurnover0.23%Turnover RatioLossP/E (Static)5.38MShares30.79952wk High2.63P/B9.29MFloat Cap1.83052wk Low--Dividend TTM2.62MShs Float2940.000Historical High--Div Yield TTM7.38%Range %1.830Historical Low3.510Avg Price1Lot Size
NCEL Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
NCEL Orderflow
Unit: --
NCEL Orderflow Trend
IntradayDayWeekMonth
No Data
NewcelX (NCEL) News
NewcelX Stem Cell Platform Strengthened by Peer-Reviewed AstroRx Study in Multiple Sclerosis
NewcelX Announces Publication Of Peer-Reviewed Study On The Potential Of AstroRx, A Human Embryonic Stem Cells-Derived Astrocyte Therapy, In The Journal Stem Cell Reports
Express News | Newcelx AG - Type B Pre-Ind Meeting With FDA Scheduled for Last Week of June
EXCLUSIVE: NewcelX Advances Diabetes Therapy Toward Human Trials With FDA Pre-IND Submission
NewcelX Files to Sell 2.26M Common Shares for Holders
Olivier Samuel Buys Handful Of Shares In NewcelX
NewcelX (NCEL) Stock Forum
$NewcelX (NCEL.US)$ EXCLUSIVE: NewcelX Expects Expanded Strategic Development Collaborations For Diabetes Drug In 2026
Benzinga
just
Outlook for 2026
The Company expects 2026 to be a year of accelerated execution, including:
Advancing NCEL-101 toward key IND-enabling milestones
Expanding strategic development collaborations
Pursuing additional financing and partnership opportunities
Accelerating development activities following establishment of an integrated post-
merger operating pla...
Benzinga
just
Outlook for 2026
The Company expects 2026 to be a year of accelerated execution, including:
Advancing NCEL-101 toward key IND-enabling milestones
Expanding strategic development collaborations
Pursuing additional financing and partnership opportunities
Accelerating development activities following establishment of an integrated post-
merger operating pla...
1
1
1
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)